| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Stimulates Thyrotropin-Independent Proliferation in Rat Thyroid Cells1
Center for Experimental Therapeutics (N.F., M.J.C., M.G.K.), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6160; Department of Pharmacology (G.V.P., J.L.M., M.G.K.), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6084
Address all correspondence and requests for reprints to: Marcelo G. Kazanietz, Center for Experimental Therapeutics, University of Pennsylvania School of Medicine, Biomedical Research Building II/III, Philadelphia, Pennsylvania 19104-6160. E-mail: marcelo{at}spirit.gcrc.upenn.edu or Judy L. Meinkoth, Department of
Several reports have indicated that protein kinase C (PKC) is an
important regulator of proliferation in thyroid cells. Unlike TSH, the
mitogenic effects of phorbol esters are accompanied by
de-differentiation. The role of individual PKC isoforms in thyroid cell
proliferation and differentiation has not been examined. Recent studies
have implicated the atypical PKC
, a phorbol ester-unresponsive
isozyme, in cell proliferation, death, and survival. We overexpressed
PKC
in Wistar rat thyroid (WRT) cells and determined that PKC
conferred TSH-independent DNA synthesis and cell proliferation. Cells
overexpressing PKC
show higher levels of phosphorylated p42/p44 MAPK
compared with vector-transfected cells. Experiments using a luciferase
reporter for Elk-1 revealed that PKC
overexpressing cells exhibit
higher basal Elk-1 transcriptional activity than vector-transfected
control cells. Interestingly, stimulation of Elk-1 transcriptional
activity by MEK1, a p42/p44 MAPK kinase, was significantly enhanced in
cells overexpressing PKC
. Strikingly, TSH retained the ability
to stimulate Tg expression in cells expressing PKC
. These results
suggest that PKC
stimulates TSH-independent mitogenesis through a
p42/p44 MAPK-dependent pathway. Unlike overexpression of Ras or phorbol
ester treatment, PKC
overexpression does not impair thyroglobulin
(Tg) expression.
This article has been cited by other articles:
![]() |
R. Mustafi, S. Cerda, A. Chumsangsri, A. Fichera, and M. Bissonnette Protein Kinase-{zeta} Inhibits Collagen I-Dependent and Anchorage-Independent Growth and Enhances Apoptosis of Human Caco-2 Cells Mol. Cancer Res., September 1, 2006; 4(9): 683 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Santiago-Walker, A. J. Fikaris, G. D. Kao, E. J. Brown, M. G. Kazanietz, and J. L. Meinkoth Protein Kinase C {delta} Stimulates Apoptosis by Initiating G1 Phase Cell Cycle Progression and S Phase Arrest J. Biol. Chem., September 16, 2005; 280(37): 32107 - 32114. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hirai and K. Chida Protein Kinase C{zeta} (PKC{zeta}): Activation Mechanisms and Cellular Functions J. Biochem., January 1, 2003; 133(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sanz-Navares, N. Fernandez, M. G. Kazanietz, and S. A. Rotenberg Atypical Protein Kinase C{zeta} Suppresses Migration of Mouse Melanoma Cells Cell Growth Differ., October 1, 2001; 12(10): 517 - 524. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |